Deceitful action by the Board & CEO at CGC
Their just released earnings along with their forward looking plans, NEVER MENTIONS THE COMPANIES INTENT OF HOLDING A VOTE ON SEPTEMBER 25, 2026 to initiate a reverse stock split.
VOTE NO!
@jimcramer Long time no speak. Way back during my days with my late friend Mark Haines. You may find my first post on X in 10 years of interest. Regards.
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth Corp.
My last investment using my proprietary analysis:
INTC at $23
You be the judge.
NVDA stock $15.12 on June 30, 2022 and by June of 2024 skyrocketed to $1208.88 prior to its 10-for-1 stock split.
The Cannabis industry will be next.
The name to buy:
Canopy Growth Corp. (CGC)
April 2024 - $14.88
July 2026 - $0.97
Be early.